when will semaglutide become generic India's surge | Opinion Generic Semaglutide: When Could It

Clinical trials reported in the European Public Assessment Report (EPAR) showed nausea affecting approximately 44% of patients, diarrhoea (30%), vomiting (24%), constipation (24%), abdominal pain (20%), and dyspepsia (9%)

Step 1: Baseline Assessment Before starting therapy, patients undergo baseline laboratory testing including blood glucose, lipid profile, thyroid function, and liver and kidney function tests

Semaglutide: $79/mo, month-to-month Tirzepatide: $129/mo, month-to-month Locked in for the life of your plan

No, never use expired semaglutide

This article reviews current research, clinical guidance, and practical considerations for patients and healthcare providers